If you are unable to view this message correctly, click here

News & Analysis on Clinical Trial Services & Contract Research And Development25-Aug-2022
LIVE WEBINAR
track
Decentralized Trial Technology - Editorial Webinar
Decentralized Trial Technology - Editorial Webinar
Outsourcing-Pharma's Webinar Now On Demand... click here
TOP HEADLINES
BMS forges multi-year research partnership with PathAI
The pharmaceutical company and the artificial intelligence pathology specialist will focus on translational research in oncology, fibrosis, and immunology.... Read more
NIH awards SBIR grant to AVM for lymphoma drug research
The National Institutes of Health grant to AVM Biotechnology will be used to evaluate a drug to treat non-Hodgkin’s lymphoma combined with standard of care.... Read more
Include patient voice at every stage of clinical processes: Within3
A leader suggests considering patient views and needs all along the clinical development path reaps a number of benefits, including time and cost savings.... Read more
Outsourcing strategists thinking farther ahead than ever: CPHI
The group’s latest report glimpses inside the minds of pharma leaders, who are looking at a product’s full life-cycle development at the preclinical stage.... Read more
 Tech Innovations: August 2022
This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.... See more
View all news headlines for:    May     Jun     Jul
EDITOR'S CHOICE
Predictive analytics could unlock precision medicine progress: AiCure
An expert from the clinical insight specialist shares how predictive analytics could reveal info about medication adherence, disease progression, and more.... Read more
ON-DEMAND WEBINARS
Decentralized Trial Technology
Taking patient interactions from trial sites to off-site is more than just a change of geography. Virtual trial success involves intelligent planning, effective data collection and management tools, advanced patient engagement technology, and more. This online event will discuss currently available DCT tools and techniques, and...
20-Jul-2022
REGISTER NOW
Clinical Development Advances
Next-level technology is transforming the process from the early end of the process to later stages of clinical development. This special edition will share innovations impacting drug discovery (such as artificial intelligence and machine learning, remote monitoring solutions streamlining data collection and management, patient-centric technology...
23-Mar-2022
REGISTER NOW
Rare & Orphan Diseases
While some diseases only impact a small percentage of the population, these unique patients still need treatments and therapies. This online event will discuss the needs of such special patients, how researchers can address recruitment and enrollment, technologies available to help overcome the challenges such...
23-Feb-2022
REGISTER NOW
Patient-centric Solutions
While patient participants are undeniably an important component of the clinical research equation, they all too often are not considered strongly enough at the various stages of the process, starting with trial design. This online event will share reasons why the patient should be thought...
17-Nov-2021
REGISTER NOW
Rare/orphan diseases, special patient population
Many diseases afflict only a small percentage of the population - these patients need treatments and therapies, but they present unique challenges. This webinar will talk about the singular needs of such patients, how to address recruitment and enrollment, and how clinical trial and pharma...
07-Jul-2021
REGISTER NOW
Innovations In Drug Delivery
In order to keep competitive, pharma firms and their partners must keep current with the latest developments in drug delivery. This webinar will bring together leading experts from various corners of the field to discuss new innovations, enhancements to existing methods, dosage issues, bioavailability concerns,...
05-May-2021
REGISTER NOW
GLOBAL INDUSTRY NEWS
WHO recommends two mAbs in fight against Ebola
The World Health Organization (WHO) has published its first guidelines for Ebola virus disease therapeutics, issuing ‘strong recommendations’ for the use of two monoclonal antibodies.... Read more
KU Leuven spin-off AstriVax raises €30m to build vaccine platform
Closing on €30m, vaccine producer, AstriVax, has raised the largest amount of seed capital in the history of KU Leuven spin-offs.... Read more
Novartis is spinning off its Sandoz business
The Swiss pharma giant wants to turn its biosimilar and generics division into a standalone company.... Read more
AskBio subsidiary readies to start clinical trials for Huntington’s Disease gene therapy
BrainVectis, a subsidiary of AskBio, has received clearance from the French authorities to start a Phase 1-2 clinical trial for its novel Huntington’s Disease gene therapy, BV-101.... Read more
PREVIOUS HEADLINES
American Kidney Fund launches resources to engage patients of color
Is it time to start rethinking mobile clinical trial apps?
BMS expands precision oncology portfolio with Turning Point acquisition
Merck engages Saama Technologies to build ‘clinical data layer’
Parkinson’s monitoring tech advances in NICE approval process
RELATED PRODUCTS
Ensure a Flexible Supply Chain in Times of Global Turmoil
ODM and CDASH in CRF design
dPCR Case Study
The Effect of PVP Viscosity on the Binding Performance in Naproxen Tablets
Standardizing data with NCI controlled terminology
Planning Your First-In-Human Trial
Consideration and Options for Prefilled Syringes
Seasonal Vaccine Manufacturing
Is Your Ancillary Supply Chain Supporting Trial Success?
Formulation Effects on Tablet Surface Properties and Film Coating Adhesion
Free Newsletters for Pharmaceuticals & Science
Explore more of our newsletters
SIGN UP
William Reed